학술논문
Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis
Document Type
Article
Author
Coronado, Pluvio J.; Gómez, Ana; Iglesias, Eva; Fasero, María; Baquedano, Laura; Sánchez, Sonia; Ramírez-Polo, Isabel; de la Viuda, Esther; Otero, Borja; Llaneza, Plácido; Mendoza, Nicolás; Lubián, Daniel M.; Calaf, Joaquín; Cancelo, María Jesús; Cano, Antonio; Branco, Camil Castelo; Doval, José Luis; Fiol, Gabriel; Gómez, María Ángeles; González, Silvia; Guinot, Misericordia; Jurado, Ana Rosa; Lete, Iñaki; Lobo, Paloma; Manubens, Montserrat; Martínez, Milagros; Mazheika, Marina; Nieto, Aníbal; Nieto, Laura; Palacios, Santiago; Plá, María Jesús; Pérez-Campos, Ezequiel; Presa, Jesús; Quereda, Francisco; Ribes, Miriam; Roca, Beatriz; Sánchez-Borrego, Rafael; Santaballa, Ana
Source
Menopause; March 2024, Vol. 31 Issue: 3 p234-242, 9p
Subject
Language
ISSN
10723714; 15300374
Abstract
The findings of this study suggest that menopausal hormone therapy could be a viable treatment alternative for breast cancer survivors experiencing menopausal symptoms, especially those with hormone receptor–negative tumors. Personalized management is recommended for each peri/postmenopausal woman facing a diminished quality of life because of menopause symptoms.